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Abstract
Background: Variation in the peroxisome-proliferator-
activated receptor g (PPARg) gene has been reported
to alter the risk for adiposity in adults.
Methods: We investigated the gender related associ-
ation between the Pro12Ala variant (rs1801282) in
obesity and insulin resistance traits in 794 peri-ado-
lescent children aged 10–12 years of Greek origin
from the Gene and Diet Attica Investigation (GENDAI)
cohort.
Results: Gender stratified analysis suggested that in
peri-adolescent boys, Ala carriers exhibited lower
measures of skinfold (triceps: 16.9"6.9 vs. 19.4"7.9
mm, ps0.014; subscapular: 9.6"4.5 vs. 11.2"5.4
mm, ps0.016) and lower adiponectin concentrations
(3.9"1.3 vs. 4.7"2.4 mg/mL, ps0.05). In peri-adoles-
cent girls, Ala carriers had lower insulin concentra-
tions (7.3"3.7 vs. 8.5"4.4 mU/mL, ps0.026) and
lower values of homeostasis model assessment of
insulin resistance (HOMA-IR) (1.5"0.8 vs. 1.8"0.96,
ps0.019). Linear regression analysis revealed that the
presence of the Ala allele in boys was a nominally
significant predictor of obesity indices, including skin-
folds (triceps: b"SE: –2.3"1.1, ps0.032; subscapular:
b"SE: –2.3"1.1, ps0.04) and adiponectin con-
centrations (b"SE: –0.7"0.4, ps0.05) after adjusting
for potential covariates. In girls, the Ala allele was a
predictor of insulin concentrations (b"SE: –1.2"0.6,
ps0.037) and HOMA-IR (b"SE: –0.24"0.13,
ps0.037).
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Conclusions: Our results suggest that adiposity in
children is influenced by the Pro12Ala polymorphism
in a gender specific manner.
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Introduction
Childhood obesity is considered to be a rapidly grow-
ing health problem worldwide (1). It affects numerous
body systems. Most notably, increased weight has
been related to hypertension, dyslipidemia, increased
tendency for blood clotting, and insulin resistance.
The factors that regulate body fat content and distri-
bution are not fully understood. With regard to dietary
intake, there is no scientific consensus whether
macronutrient composition affects energy metabo-
lism and body fat distribution, beyond energy con-
tent. However, specific macronutrient composition of
the diet may be one of the important environmental
factors that control nutrient partitioning to specific
adipose tissue depots, without affecting total body
weight (2).
The human peroxisome proliferator-activated
receptor-g (PPARg) plays a key role in the regulation
of lipid and glucose homeostasis, in the differentia-
tion of adipocytes and in fatty acid storage (3, 4). The
Pro12Ala polymorphism has been widely investigated
in relation to various disorders including obesity
(5–7). However, the association of the Ala allele with
a higher risk of obesity has not been consistent in all
studies, suggesting heterogeneity in its effect. Alter-
natively, a combination of chance findings and low
power may also contribute to differing results. It has
been shown that PPARg expression is attenuated in
visceral adipose tissue in lean subjects (8, 9). This
may suggest a link between the Pro12Ala polymor-
phism and regulation of regional adiposity and body
weight.
In light of the increasing prevalence of pediatric
obesity, it is important to assess the potential impact
of the Pro12Ala polymorphism in the PPARg gene at
an earlier stage of life. This has been attempted by
several groups, with largely inconsistent findings
(10–13). It has recently been shown that in young chil-
dren (13), the Pro12Ala polymorphism is associated
with increased adiposity exclusively in girls. The mis-
match regarding findings from adult and pediatric
cohorts are likely due to the influence of unmeasured
factors, such as diet, or age-specific effects (14). In the
present study, a gender related association between
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the Pro12Ala variant of the PPARg gene and obesity
traits in children was investigated.
Subjects and methods
Subjects
The Gene and Diet Attica Investigation (GENDAI) target
population was children attending the fifth and sixth grades
living in the Attica region of Greece, as described previously
(15). The GENDAI cohort is comprised of 1138 adolescent
children (53% girls; mean age: 11.2"0.7 years) randomly
selected from elementary schools in Attica. The research
study was approved by the Institutional Review Board of
Harokopio University, and the Greek Ministry of Education.
Informed consent for genetic analysis of all participants was
obtained from the children’s parents.
Dietary methodology
Dietary information regarding GENDAI study was evaluated
through two non-consecutive 24 h recalls, three to ten days
apart. The 24 h recalls were analyzed using the Nutritionist
Pro software, version 2.2 (Axxya Systems-Nutritionist Pro
Inc, Stafford, TX, USA). The mean nutrient intake from the
two recalls was used for estimation of usual nutrient intake.
Physical activity assessment
Coinciding with the dates of the dietary recalls, participants
completed a physical activity checklist recall two times (16).
This instrument queried the child’s time spent on mild, mod-
erate, and strenuous exercise, plus sedentary pursuits, such
as time spent viewing TV or playing computer/video games,
during the previous 24 h. Then, the mean MET (metabolic
cost of activity) scores were calculated from the children’s
reported history of physical activity, taking into account
minutes of activity as well as minutes of inactivity.
Sexual maturity assessment
Sexual maturity status, according to Tanner’s criteria for
breast, pubic hair, and genital development (17) was self-
evaluated. In particular, girls rated breast and pubic hair
development and boys rated genital development and pubic
hair development using a series of standardized photos, in
the presence of the team’s pediatrician.
Anthropometry assessment
Physical measurements of body weight and height were
obtained in light clothing without shoes. Body mass index
(BMI) was computed as weight (kg)/height (m2). In addition,
a soft tape measure was used to record waist circumference
(cm) and hip circumference (cm). The waist-to-hip ratio
(WHR) was calculated as an index of central adiposity. Two
measurements of right side triceps and subscapular skin-
folds were performed with Lange skinfold callipers (Cam-
bridge Scientific Instruments, Cambridge, MA, USA) to
obtain a mean measurement with precision of 0.2 mm.
Blood sampling
Ten mL of venous blood was collected after an overnight fast
(G10 h). The samples were placed in plain tubes as well as
EDTA-containing tubes to obtain separate aliquots for serum
and plasma. We present data on 794 children (420 girls and
374 boys) for which complete information and high-quality
genotype data was available.
Genotyping
Genotyping of the Pro12Ala polymorphism (rs1801282) was
done as part of a larger panel and was performed using
the iPLEX MassARRAY platform (Sequenom). (http://www.
sequenom.com/Assets/pdfs/appnotes/8876-006.pdf).
Statistical methods
All statistical analyses were performed using SPSS 13.0 for
Windows (SPSS Inc., Chicago, IL, USA). The normal distri-
bution of the investigated variables was assessed using the
Kolmogorov-Smirnov criteria. For all analyses we used log-
transformed values for measures that were not normally
distributed, namely BMI and waist. However, in our Tables,
untransformed mean values are presented. Categorical data
are presented as frequencies or proportions (%). Distribu-
tions of frequencies of categorical variables were analyzed
using the x2-test of independence. The association of geno-
types with adiposity outcomes was tested using multiple
linear regressions, after controlling for the effects of gender
and minutes of sedentary activity, as these variables were
significant predictors. Interaction terms between genotypes
and gender were also tested in each model and when sig-
nificant, the analysis was stratified by gender. The critical
p-value at which significance was accepted, was an a val-
ues0.05. All reported p-values are based on two-sided tests.
Results
The overall frequency of the Ala allele was f(Ala:0.8),
and the genotype frequencies were in Hardy-Wein-
berg equilibrium. Due to the small number of
Ala12Ala homozygotes (ns6), all analyses were per-
formed under a dominant genetic model. Gender
stratified analysis suggested that in peri-adolescent
boys, Ala carriers exhibited lower measures of skin-
folds (triceps: 16.9"6.9 vs. 19.4"7.9 mm, ps0.014;
subscapular: 9.6"4.5 vs. 11.2"5.4 mm, ps0.016) and
lower adiponectin concentrations (3.9"1.3 vs. 4.7"
2.4 mg/mL, ps0.05) (Table 1). No significant differ-
ence was observed between genotype groups for age,
Tanner stage, sedentary activity, energy and
different types of fat intake (expressed as % of total
energy), or for the other biochemical markers.
In peri-adolescent girls, Ala carriers had lower
concentrations levels (7.3"3.7 vs. 8.5"4.4 mU/mL,
ps0.026), homeostasis model assessment of insulin
resistance (HOMA-IR) (1.5"0.8 vs. 1.8"0.96, ps
0.019) and saturated fatty acids (SFA) intake (14.8"3
vs. 13.5"2.9%, ps0.002) compared with the Pro/Pro
girls (Table 1). These results persisted after adjust-
ment for BMI for insulin concentrations (b"SE:
–1.2"0.6, ps0.037), HOMA-IR (b"SE: –0.24"0.13,
ps0.037) and SFA intake (b"SE: –1.2"0.4, ps0.003)
(Table 2). In summary, linear regression analysis after
adjusting for age, Tanner stage and minutes of inac-
tivity, revealed that the presence of the Ala allele in
boys was a nominally significant predictor of obesity
indices, such as skinfolds (triceps: b"SE: –2.3"1.1,
ps0.032; subscapular: b"SE: –2.3"1.1, ps0.04), and
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Table 1 Anthropometric, pubertal stage, dietary intake, adiposity and biochemical parameters depending on the Pro12Ala
polymorphism.
Girls Boys
Pro/Pro Ala allele p-Value Pro/Pro Ala allele p-Value
(ns356) (ns64) (ns313) (ns61)
Age, years 11.1"0.6 11.2"0.7 0.43 11.2"0.7 11.1"0.6 0.36
Tanner stage, % (I/II/III/IV/V) 9.3/33.7/39.9/ 14.1/26.6/ 0.35 12.5/45.4/31/ 14.8/44.3/ 0.44
14.6/2 50/9.4 8.9/1.9 34.4/6.6
Sedentary activity, min/day 113.9"74.6 114.9"83.9 0.92 143"102 127"77 0.25
Energy, kcal/day 1764"524 1788"543 0.73 2008"596 2024"751 0.87
TF, % of total energy 40"6.5 38.5"5.8 0.052 40.2"7 41"7 0.41
SFA, % of total energy 14.8"3 13.5"2.9 0.002 14.7"3.6 15"3.7 0.52
MUFA, % of total energy 16.2"4.3 16.2"4.2 0.99 16.4"4.2 16.8"4.4 0.53
PUFA, % of total energy 4.7"1.5 4.7"1.6 0.73 4.9"1.5 4.6"1.4 0.23
Anthropometry
Weight, kg 44.2"9.4 43.6"10.3 0.57 44.8"9.4 42.9"9.3 0.13
BMI, kg/m2 19.9"3.4 19.6"3.6 0.55 20.4"3.4 19.7"3.4 0.11
Skinfolds
Triceps, mm 19.8"7.2 20"8.0 0.92 19.4"7.9 16.9"6.9 0.014
Subscapular, mm 11.7"5.3 12.3" 6.1 0.94 11.2"5.4 9.6"4.5 0.016
Waist circumference, cm 67.3"9.1 68.9"9.6 0.67 70.7"9.6 68.7"9.5 0.10
Body fatness, Slaughter equation 31.4"11.5 31.9"12.5 0.80 26.2"10.7 22.9"7.9 0.063
Biochemical indices
Total cholesterol, mg/dL 184.3"28.3 181.2"28.4 0.49 190"26.9 186.7"27.2 0.38
HDL-cholesterol, mg/dL 51.4"9.7 51.2"10.9 0.90 53.4"10.1 53.4"9.9 70.99
LDL-cholesterol, mg/dL 119.2"23 118.3"21.9 0.76 124"21.9 120.1"23.2 0.23
Triglycerides, mg/dL 66.7"22 63.4"20.4 0.30 60.3"20.9 66.1"26.5 0.12
Glucose, mg/dL 85.1"8.6 84.1"8.5 0.40 86.8"8.4 85.6"8.9 0.31
Insulin, mg/dL 8.5"4.4 7.3"3.7 0.026 7.2"3.9 6.5"3 0.24
HOMA-IR, % 1.8"0.96 1.5"0.8 0.019 1.6"0.94 1.6"1 0.96
Leptin, pg/mL 7247"6471 7150"7174 0.94 5973"451 7212"1275 0.42
Adiponectin, mg/mL 4.5"2.2 4.7"2.7 0.42 4.7"2.4 3.9"1.3 0.032
Data are presented as means"SD. Values in bold font type. TF, total fat; SFA, saturated fatty acids; MUFA, monounsaturated
fatty acids; PUFA, polyunsaturated fatty acids; HDL, high density lipoprotein; LDL, low density lipoprotein; BMI, body mass
index; HOMO-IR, homeostasis model assessment of insulin resistance. Bold: p-0.05. To transform to SI units, the conversion
factors are: total cholesterol, HDL-, LDL-cholesterol=0.026; glucose=0.055; triglycerides=0.011; insulin=0.0417.
Table 2 Linear regression analysis stratified by gender for adiposity measures and insulin resistance.
Boys Girls
Dependent variables b"SE p-Value Dependent variables b"SE p-Value
Triceps, mm 2.3"1.1 0.032 Insulin, mg/dL 1.2"0.6 0.037
Subscapular, mm 2.3"1.1 0.04 HOMA-IR 0.24"0.13 0.037
Adiponectin, mg/mL 0.7"0.4 0.05 SFA, % of total energy 1.2"0.4 0.003
Adjustment has been made for age, Tanner stage and sedentary activity for all variables. Adiponectin and saturated fat (%
of total energy) were additionally adjusted for BMI. B-coefficients are values comparing Pro/Pro with Ala carriers. HOMO-IR,
homeostasis model assessment of insulin resistance; SFA, saturated fatty acids; SE, standard error. Bold: p-0.05.
adiponectin concentrations (b"SE: –0.7"0.4, ps0.05)
(Table 2).
Discussion
Our study extends previous findings (13) in children
and suggests that there is a gender specific associa-
tion of the Pro12Ala polymorphism with measures of
adiposity at certain ages. While the frequency of the
Ala12 allele (0.08) was similar to that reported in two
Greek cohorts of children at different ages (0.07) (13,
18), no significant associations between PPARg vari-
ants and anthropometric indices were identified in
our pediatric cohort before gender stratification. Peri-
adolescent boys with the Ala allele had lower skinfold
measures (triceps and subscapular) compared to
those with the Pro allele. This novel effect in children
seems consistent with reports suggesting a protective
effect of the Ala allele against obesity and improved
insulin sensitivity in adults (19). Similar findings on
obesity indices, depending on gender, were shown
previously in adults (20) as well as children (21).
These gender differences might be attributed either
to sex-linked genes and/or variations in sex hor-
mones. The different fat distribution patterns seen in
the two genders could partially explain the etiology
of sex variability on anthropometry, depending on the
genotype. The lower concentrations of fasting blood
insulin and lower HOMA-IR values that we found in
girls confirm previous findings in obese Italian chil-
dren (11). Additionally, female Ala carriers had a sig-
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nificantly lower intake of SFA. It was previously
shown in type 2 diabetic patients that carriers of the
Ala allele had a lower energy intake per kilogram of
body weight, suggesting the Ala allele was associated
with greater food efficiency (7). The lower concentra-
tions of adiponectin found in boys with the Ala allele
were also seen in young adult males from a Japanese
cohort (22), suggesting interaction with the adiponec-
tin gene. The screening analysis using BMI did not
reveal any significant association with the Ala allele,
which is consistent with recent results from an 11 to
24-year-old cohort from Mexico (1210 students) (12).
In summary, we found evidence of a possible effect
of the Ala allele at the Pro12Ala locus in the PPARg
gene on adiposity indices in boys, and SFA intake and
insulin indices in girls. These results add to the epi-
demiologic data for this variant in children. The mod-
est study size or heterogeneity of the effect in boys
and girls at this age may account for the gender spe-
cific findings.
The cross-sectional design does limit the potential
to reveal causal relationships. However, these find-
ings may motivate further study in larger cohorts with
longitudinal data in order to more fully understand
the impact of this gene variant on growth and devel-
opment of obesity and diabetes in boys and girls.
Acknowledgements
The authors would like to thank the field investigators for
their assistance in physical examination, biochemical anal-
ysis and nutritional assessment. Above all, the authors thank
the study participants and their families for their time and
effort to help create both paediatric cohorts. The collection
of the GENDAI cohort was funded by Coca-Cola Hellas. The
genotyping was funded by NIDDK K23DK067288 awarded to
HNL. All authors were responsible for reviewing the manu-
script. We declare that we have no conflict of interests.
References
1. Deckelbaum RJ, Williams CL. Childhood obesity: the
health issue. Obes Res 2001;9(Suppl 4):239S–43S.
2. Piers LS, Walker KZ, Stoney RM, Soares MJ, O’Dea K. The
influence of the type of dietary fat on postprandial fat oxi-
dation rates: monounsaturated (olive oil) vs. saturated fat
(cream). Int J Obes Relat Metab Disord 2002;26:814–21.
3. Argmann CA, Cock TA, Auwerx J. Peroxisome prolifera-
tor-activated receptor gamma: the more the merrier? Eur
J Clin Invest 2005;35:82–92; discussion 80.
4. Heikkinen S, Auwerx J, Argmann CA. PPARgamma in
human and mouse physiology. Biochim Biophys Acta
2007;1771:999–1013.
5. Barbieri M, Rizzo MR, Papa M, Acampora R, De Angelis L,
Olivieri F, et al. Role of interaction between variants in the
PPARG and interleukin-6 genes on obesity related meta-
bolic risk factors. Exp Gerontol 2005;40:599–604.
6. Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H,
Nakayama M, et al. A possible association of Pro12Ala
polymorphism in peroxisome proliferator-activated recep-
tor gamma2 gene with obesity in native Japanese in Indo-
nesia. Diabetes Metab Res Rev 2005;21:465–9.
7. Vaccaro O, Lapice E, Monticelli A, Giacchetti M, Castaldo
I, Galasso R, et al. Pro12Ala polymorphism of the PPAR-
gamma2 locus modulates the relationship between
energy intake and body weight in type 2 diabetic
patients. Diabetes Care 2007;30:1156–61.
8. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L,
Auwerx J, et al. Depot-specific differences in adipose
tissue gene expression in lean and obese subjects.
Diabetes 1998;47:98–103.
9. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo
I, Willett WC, et al. Interaction between a peroxisome
proliferator-activated receptor gamma gene polymor-
phism and dietary fat intake in relation to body mass.
Hum Mol Genet 2003;12:2923–9.
10. Cecil JE, Fischer B, Doney AS, Hetherington M, Watt P,
Wrieden W, et al. The Pro12Ala and C-681G variants of
the PPARG locus are associated with opposing growth
phenotypes in young schoolchildren. Diabetologia 2005;
48:1496–502.
11. Scaglioni S, Verduci E, Salvioni M, Biondi ML, Radaelli
G, Agostoni C, et al. PPAR-gamma2 Pro12Ala variant,
insulin resistance and plasma long-chain polyunsaturat-
ed fatty acids in childhood obesity. Pediatr Res 2006;60:
485–9.
12. Chen L, Velasco Mondragon HE, Lazcano-Ponce E, Col-
lins A, Shugart YY. Effect of the peroxisome prolifera-
tors-activated receptor (PPAR) gamma 3 gene on BMI in
1,210 school students from Morelos, Mexico. Pac Symp
Biocomput 2006:467–77.
13. Lagou V, Scott RA, Manios Y, Chen TL, Wang G, Gram-
matikaki E, et al. Impact of peroxisome proliferator-acti-
vated receptors gamma and delta on adiposity in
toddlers and preschoolers in the GENESIS Study. Obe-
sity (Silver Spring) 2008;16:913–8.
14. Lasky-Su J, Lyon HN, Emilsson V, Heid IM, Molony C,
Raby BA, et al. On the replication of genetic associations:
timing can be everything! Am J Hum Genet 2008;82:
849–58.
15. Papoutsakis C, Vidra NV, Hatzopoulou I, Tzirkalli M, Far-
maki AE, Evagelidaki E, et al. The Gene-Diet Attica inves-
tigation on childhood obesity (GENDAI): overview of the
study design. Clin Chem Lab Med 2007;45:309–15.
16. Sallis JF, Strikmiller PK, Harsha DW, Feldman HA, Ehlin-
ger S, Stone EJ, et al. Validation of interviewer- and self-
administered physical activity checklists for fifth grade
students. Med Sci Sports Exerc 1996;28:840–51.
17. Tanner JM. The measurement of maturity. Trans Eur
Orthod Soc 1975:45–60.
18. Dedoussis GV, Theodoraki EV, Manios Y, Yiannakouris
N, Panagiotakos D, Papoutsakis C, et al. The Pro12Ala
polymorphism in PPARgamma2 gene affects lipid para-
meters in Greek primary school children: a case of gene-
to-gender interaction. Am J Med Sci 2007;333:10–5.
19. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen
L, Kuusisto J, et al. A Pro12Ala substitution in PPARgam-
ma2 associated with decreased receptor activity, lower
body mass index and improved insulin sensitivity. Nat
Genet 1998;20:284–7.
20. Morini E, Tassi V, Capponi D, Ludovico O, Dallapiccola
B, Trischitta V, et al. Interaction between PPARgamma2
variants and gender on the modulation of body weight.
Obesity (Silver Spring) 2008;16:1467–70.
21. Jacobsson JA, Danielsson P, Svensson V, Klovins J, Gyl-
lensten U, Marcus C, et al. Major gender difference in
association of FTO gene variant among severely obese
children with obesity and obesity related phenotypes.
Biochem Biophys Res Commun 2008;368:476–82.
22. Takata N, Awata T, Inukai K, Watanabe M, Ohkubo T,
Kurihara S, et al. Pro12Ala substitution in peroxisome
proliferator-activated receptor gamma 2 is associated
with low adiponectin concentrations in young Japanese
men. Metabolism 2004;53:1548–51.
